Laia Tremosa, Autor a Institut de Neurociències

September 28, 2021 In News By Laia Tremosa

New mouse model for studying the cognitive protection mechanisms in Alzheimer’s

Alzheimer’s is a neurodegenerative disease that features the accumulation of the beta-amyloid peptide and Tau protein in the brain, which are associated with deficits in the neuronal connections and with dementia. However, researchers have recently discovered a type of people that despite the accumulation of...

September 23, 2021 In Uncategorized By Laia Tremosa

Dr. David Bartres-Faz new chair of the ‘Reserve, Resilience and Protective Factors’ PIA of the Alzheimer’s Association International Society

At its annual executive meeting, on September 20, 2021, the professional interest area (PIA) 'Reserve, Resilience and Protective Factors' of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment, (ISTAART) officially announced that Dr. David Bartrés Faz, group leader at the Institute of...

September 9, 2021 In News By Laia Tremosa

Light-activated drugs: localized medicine without side effects

Photopharmacology is an emerging area of science based on the development of photosensitive drugs, that is, drugs that activate with light. A team from IDIBELL and the University of Barcelona has worked on two treatments based on this innovative technology: a morphine derivative that does...

July 29, 2021 In News By Laia Tremosa

New findings on the function of mitofusin 2 in the cellular energy metabolism

Mitofusin 2 is a key protein in the regulation of the physiology of mitochondria ─cellular organelles that produce energy─ involved in several neurodegenerative and cardiovascular diseases, as well as in cancer. Now, a study published in the journal EMBO Reports reveals that the regulation of the bioenergetic...

July 21, 2021 In News By Laia Tremosa

CaixaResearch call for Health Research promotes UB research

La Caixa Foundation announced today the thirty projects that were selected in the call CaixaResearch on Health Research 2021. These are excellence projects on biomedicine and research on health presented by research centres and universities from Spain and Portugal, funded with a total of 22.1 million...

July 19, 2021 In News, Uncategorized By Laia Tremosa

Training the next generation of Neuroscience leaders

Last Thursday 15th of July, the Institute of Neurosciences of the University of Barcelona held a meeting for all young researchers to help them push their careers to the next level. ...

July 16, 2021 In News By Laia Tremosa

Identification and characterization of two new disease genes implicated in developmental brain diseases

Recent studies led by Dr. Raúl Estévez from the Institute of Neurosciences of the University of Barcelona, have resulted in the identification of the genes responsible for two types of brain development diseases. On the one hand, in a collaboration with the group of Pankaj B Agrawal, from Boston Children's Hospital,...

July 16, 2021 In News By Laia Tremosa

Vocal music boosts the recovery of language functions after stroke

Research has shown that listening to music daily improves language recovery in patients who have experienced a stroke. However, the neural mechanisms underlying the phenomenon have so far remained unknown. A study conducted at the University of Helsinki and the Turku University Hospital Neurocenter compared the...

June 30, 2021 In News By Laia Tremosa

¿Estas interesado en hacer ciencia a través de las artes escenicas?

Del 29 de Junio al 1 de Julio se desarrollará la primera acción de la European Performing Science Night 2021 en la sede de la Fundación Épica La Fura dels Baus. Se trata de un taller en el que participarán un total de 27 investigadores pertenecientes a al Instituto...

June 29, 2021 In News By Laia Tremosa

LSL60101 compound reduces neuroinflammation and improves cognition in animal models with Alzheimer’s

The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer’s disease. This is stated in the recent studies by the Research Group on Medicinal Chemistry and Pharmacology of Neurodegenerative Diseases of...